Serum YKL-40 and bone marrow angiogenesis in multiple myeloma.
Mylin
Anne K
AK
Andersen
Niels F
NF
Johansen
Julia S
JS
Abildgaard
Niels
N
Heickendorff
Lene
L
Standal
Therese
T
Gimsing
Peter
P
Knudsen
Lene M
LM
D054392:Adipokines; D001853:Bone Marrow / Q000473:pathology*; D000071451:Chitinase-3-Like Protein 1; D004730:Endothelium, Vascular / Q000502:physiology; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D005909:Glioblastoma / Q000097:blood; D006023:Glycoproteins / Q000097:blood* / Q000235:genetics; D006801:Humans; D037102:Lectins; D009101:Multiple Myeloma / Q000097:blood* / Q000401:mortality / Q000473:pathology*; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000097:blood*; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D016019:Survival Analysis; D014471:Umbilical Veins / Q000502:physiology
D054392:Adipokines; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D006023:Glycoproteins; D037102:Lectins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D016222:Fibroblast Growth Factor 2